Clinical Trial Update: Near Infrared Spectroscopy (St02)

View source ↗

Summary

This entry notes the completed clinical trial using near-infrared spectroscopy (St02) in septic shock conducted by Beth Israel Deaconess Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Septic Shock | Status: COMPLETED